Atlas Brown’s Bristol-Myers Squibb BMY Stock Holding History

Atlas Brown’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$771K	Sell	13,373 -100	-0.7%	-$5.74K	0.21%	109
2026 Q1	$817K	Sell	13,473 -1	-0%	-$58	0.25%	97
2025 Q4	$727K	Sell	13,474 -2,689	-17%	-$129K	0.22%	107
2025 Q3	$729K	Sell	16,163 -15	-0.1%	-$701	0.22%	103
2025 Q2	$749K	Sell	16,178 -60	-0.4%	-$2.94K	0.24%	93
2025 Q1	$990K	Sell	16,238 -321	-2%	-$18.7K	0.35%	80
2024 Q4	$937K	Buy	16,559 +518	+3%	+$28.9K	0.32%	82
2024 Q3	$830K	Sell	16,041 -1,783	-10%	-$83.6K	0.29%	87
2024 Q2	$740K	Buy	17,824 +29	+0.2%	+$1.3K	0.27%	94
2024 Q1	$965K	Sell	17,795 -269	-1%	-$13.7K	0.35%	82
2023 Q4	$927K	Sell	18,064 -246	-1%	-$12.9K	0.38%	77
2023 Q3	$1.06M	Sell	18,310 -2,055	-10%	-$126K	0.48%	65
2023 Q2	$1.3M	Buy	20,365 +75	+0.4%	+$5.03K	0.57%	53
2023 Q1	$1.41M	Buy	20,290 +184	+0.9%	+$13K	0.65%	49
2022 Q4	$1.45M	Sell	20,106 -273	-1%	-$20.6K	0.71%	47
2022 Q3	$1.45M	Buy	20,379 +47	+0.2%	+$3.41K	0.74%	41
2022 Q2	$1.57M	Buy	20,332 +201	+1%	+$15.3K	0.74%	42
2022 Q1	$1.47M	Sell	20,131 -295	-1%	-$19.8K	0.6%	50
2021 Q4	$1.27M	Buy	20,426 +1,083	+6%	+$63.5K	0.49%	60
2021 Q3	$1.15M	Buy	19,343 +2	+0%	+$132	0.5%	67
2021 Q2	$1.29M	Buy	19,341 +2,391	+14%	+$156K	0.56%	56
2021 Q1	$1.07M	Buy	16,950 +412	+2%	+$25.6K	0.51%	62
2020 Q4	$1.03M	Sell	16,538 -297	-2%	-$18.3K	0.53%	61
2020 Q3	$1.01M	Buy	16,835 +2	+0%	+$120	0.6%	59
2020 Q2	$988K	Sell	16,833 -183	-1%	-$10.9K	0.63%	50
2020 Q1	$948K	Buy	17,016 +2,245	+15%	+$137K	0.74%	49
2019 Q4	$948K	Buy	14,771 +4,903	+50%	+$281K	0.59%	56
2019 Q3	$500K	Buy	9,868 +803	+9%	+$37.7K	0.36%	81
2019 Q2	$411K	Buy	9,065 +1,402	+18%	+$65.3K	0.28%	95
2019 Q1	$366K	Sell	7,663 -97	-1%	-$4.83K	0.26%	102
2018 Q4	$403K	Sell	7,760 -498	-6%	-$26.8K	0.31%	89
2018 Q3	$513K	Sell	8,258 -3,198	-28%	-$190K	0.32%	91
2018 Q2	$644K	Buy	11,456 +2	+0%	+$108	0.15%	71
2018 Q1	$724K	Buy	11,454 +882	+8%	+$56.7K	0.13%	60
2017 Q4	$674K	Buy	10,572 +501	+5%	+$31.3K	0.12%	69
2017 Q3	$642K	Buy	10,071 +1,802	+22%	+$105K	0.14%	65
2017 Q2	$461K	Sell	8,269 -118	-1%	-$6.42K	0.4%	77
2017 Q1	$456K	Buy	8,387 +4	+0%	+$219	0.36%	75
2016 Q4	$452K	Hold	8,383	–	–	0.19%	73
2016 Q3	$452K	Sell	8,383 -31	-0.4%	-$1.99K	0.19%	73
2016 Q2	$619K	Sell	8,414 -249	-3%	-$17.6K	0.25%	56
2016 Q1	$553K	Buy	8,663 +322	+4%	+$20.3K	0.23%	54
2015 Q4	$514K	Sell	8,341 -32	-0.4%	-$2.12K	0.33%	51
2015 Q3	$496K	Hold	8,373	–	–	0.21%	55
2015 Q2	$535K	Sell	8,373 -63	-0.7%	-$4.15K	0.21%	56
2015 Q1	$544K	Buy	8,436 +1	+0%	+$63	0.15%	52
2014 Q4	$498K	Buy	8,435 +2	+0%	+$113	0.13%	59
2014 Q3	$432K	Buy	8,433 +251	+3%	+$12.5K	0.16%	64
2014 Q2	$397K	Buy	8,182 +150	+2%	+$7.39K	0.2%	64
2014 Q1	$417K	Hold	8,032	–	–	0.22%	55
2013 Q4	$427K	Sell	8,032 -14,275	-64%	-$727K	0.3%	41
2013 Q3	$1.03M	Sell	22,307 -5,670	-20%	-$249K	0.77%	17
2013 Q2	$1.25M	Buy	+27,977	New	+$1.21M	0.27%	46

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Atlas Brown's BMY Position: Q2 2026 in Review

Atlas Brown reduced its Bristol-Myers Squibb (BMY) stake by 0.74% in Q2 2026, selling an estimated $5.74K and leaving 13,373 shares worth $771K. The position accounts for 0.21% of the portfolio, ranked #109.

Atlas Brown first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.57M in Q2 2022. 936 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Atlas Brown held 13,373 shares of Bristol-Myers Squibb worth $771K as of Q2 2026.
Atlas Brown sold 100 Bristol-Myers Squibb shares in Q2 2026, an estimated $5.74K.
Bristol-Myers Squibb made up 0.21% of Atlas Brown's portfolio in Q2 2026, its #109 holding.
Atlas Brown first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
Atlas Brown's Bristol-Myers Squibb position peaked at $1.57M in Q2 2022.
936 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Atlas Brown's 13F filing for Q2 2026, filed 9 Jul 2026.